Point72 Asia (Singapore)’s Cartesian Therapeutics RNAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,824
Closed -$49.3K 1261
2024
Q2
$49.3K Buy
+1,824
New +$49.3K 0.01% 657